Clinical Pharmacology and Drug Toxicity Practice Questions

Q: Red urine without RBCs is seen in which of the following conditions?

Following Rifampicin ingestion. ### Explanation The presence of red urine without red blood cells (RBCs) on microscopy is a classic clinical finding that distinguishes **discoloration (pseudohematuria)** from true hematuria. **1. Why Option D is Correct:** **Rifampicin**, a key bactericidal drug used in Tuberculosis (RNTCP/NTEP), is a highly lipid-soluble, macrocyclic antibiotic. It is excreted through bile and urine. A unique characteristic of Rifampicin is its ability to cause a **harmless, reddish-orange discoloration** of all body secretions, including urine, sweat, saliva, and tears. Since this is due to the pigment of the drug itself and not due to bleeding, microscopy will show **zero RBCs**. **2. Why Incorrect Options are Wrong:** * **Lupus Nephritis (A):** This is an inflammatory glomerulonephritis. It typically presents with **microscopic or macroscopic hematuria**, meaning RBCs (often dysmorphic) will be present in the urine. * **Pyelonephritis (B):** This is an upper urinary tract infection. It is characterized by pyuria (WBCs) and frequently involves **hematuria** due to mucosal inflammation. * **Hemolytic Uremic Syndrome (C):** HUS involves microangiopathic hemolytic anemia and acute kidney injury. It typically presents with **hematuria** and hemoglobinuria. **3. High-Yield Clinical Pearls for NEET-PG:** * **Other causes of red urine without RBCs:** Myoglobinuria (rhabdomyolysis), Hemoglobinuria (intravascular hemolysis), and ingestion of Beetroot (Beeturia) or Senna. * **Rifampicin Counseling:** Always counsel patients that orange-red urine is a side effect, not a sign of toxicity, to ensure treatment adherence. * **Mechanism of Rifampicin:** Inhibits DNA-dependent RNA polymerase. * **Drug Interactions:** Rifampicin is a potent **Cytochrome P450 inducer**, leading to decreased plasma levels of drugs like Warfarin and Oral Contraceptive Pills (OCPs).

Q: Which drug may lead to hemolysis in a child with G6PD deficiency?

Primaquine. ### Explanation **Correct Option: B. Primaquine** **Mechanism of Hemolysis in G6PD Deficiency:** Glucose-6-Phosphate Dehydrogenase (G6PD) is the rate-limiting enzyme in the pentose phosphate pathway, responsible for generating **NADPH**. In RBCs, NADPH is essential to maintain **reduced glutathione**, which neutralizes reactive oxygen species (ROS). **Primaquine** is an oxidizing agent. In G6PD-deficient individuals, the inability to regenerate reduced glutathione leads to the oxidation of hemoglobin into insoluble precipitates called **Heinz bodies**. These damage the RBC membrane, leading to acute hemolytic anemia. This is a classic example of **Pharmacogenetics**. **Analysis of Incorrect Options:** * **A. Penicillin:** While Penicillin can cause immune-mediated hemolytic anemia (Type II Hypersensitivity), it is not an oxidizing agent and does not trigger G6PD-related hemolysis. * **C. Ceftriaxone:** A third-generation cephalosporin that does not possess significant oxidizing potential. * **D. Erythromycin:** A macrolide antibiotic that is safe in G6PD deficiency. **High-Yield Clinical Pearls for NEET-PG:** * **Other Trigger Drugs:** Dapsone (highest risk), Nitrofurantoin, Sulfonamides (e.g., Co-trimoxazole), and Ciprofloxacin. * **Non-Drug Triggers:** Fava beans (Favism) and infections (most common cause of hemolysis). * **Peripheral Smear Findings:** Look for **Heinz bodies** (denatured hemoglobin) and **Bite cells** (deformed RBCs after splenic macrophages remove Heinz bodies). * **Inheritance:** G6PD deficiency is an **X-linked recessive** disorder, predominantly affecting males. * **Primaquine Rule:** Always screen for G6PD deficiency before initiating Primaquine for the radical cure of *P. vivax* or *P. ovale*.

Q: Which one of the following drugs is associated with the development of a lupus-like syndrome, especially in patients identified as "slow acetylators"?

Procainamide. ### Explanation **Correct Option: D. Procainamide** Procainamide is a Class IA antiarrhythmic drug notorious for causing **Drug-Induced Lupus Erythematosus (DILE)**. The underlying mechanism involves its metabolism via the **N-acetyltransferase (NAT)** enzyme. In the liver, procainamide is acetylated to N-acetylprocainamide (NAPA). Patients who are **"slow acetylators"** have a genetic deficiency of this enzyme, leading to the accumulation of the parent drug. This excess drug undergoes alternative oxidative metabolism, forming reactive metabolites that trigger an autoimmune response, typically manifesting as joint pain, fever, and pleuritis. **Analysis of Incorrect Options:** * **A. Amiodarone:** Known for causing pulmonary fibrosis, thyroid dysfunction (hypo/hyperthyroidism), and corneal microdeposits, but not a lupus-like syndrome. * **B. Clonidine:** An alpha-2 agonist used for hypertension; its primary side effects include sedation, dry mouth, and rebound hypertension upon abrupt withdrawal. * **C. Nitroglycerin:** A vasodilator used in angina; common side effects include throbbing headache, flushing, and orthostatic hypotension. **High-Yield Clinical Pearls for NEET-PG:** * **Mnemonic for DILE drugs:** "**S**hip **H**as **P**ushed **M**e" (**S**ulfonamides, **H**ydralazine, **I**soniazid, **P**rocainamide, **P**henytoin, **M**ethyldopa). * **Serology:** DILE is characterized by the presence of **Anti-Histone Antibodies** (95% sensitivity). Unlike systemic lupus (SLE), Anti-dsDNA antibodies are usually absent. * **Prognosis:** Symptoms typically resolve upon discontinuation of the offending drug. * **Procainamide specific:** It has the highest risk of inducing ANA (Antinuclear Antibody) positivity, occurring in up to 80% of patients over time.

Q: Bone marrow aplasia is not seen with which of the following drugs?

Levodopa. **Explanation:** Bone marrow aplasia (aplastic anemia) is a serious condition characterized by the pancytopenia of peripheral blood and a hypocellular bone marrow. In the context of pharmacology, it is often a result of drug-induced myelosuppression. **Why Levodopa is the Correct Answer:** **Levodopa** is a precursor of dopamine used in the treatment of Parkinson’s disease [1]. Its primary side effects are gastrointestinal (nausea, vomiting), cardiovascular (arrhythmias, orthostatic hypotension), and neurological (dyskinesias, hallucinations) [1], [2]. It is **not** associated with bone marrow suppression or aplastic anemia [1]. **Analysis of Incorrect Options:** * **Azathioprine:** This is a potent immunosuppressant (prodrug of 6-mercaptopurine). Its primary dose-limiting toxicity is **bone marrow suppression**, leading to leukopenia and occasionally full aplasia, especially in patients with Thiopurine Methyltransferase (TPMT) deficiency. * **Furosemide:** While primarily a loop diuretic, sulfonamide-derived drugs like Furosemide can rarely cause idiosyncratic bone marrow suppression and blood dyscrasias. * **Chloramphenicol:** This is a classic "high-yield" cause of bone marrow aplasia. It causes two types of toxicity: a dose-dependent, reversible suppression and a rare, **dose-independent, irreversible aplastic anemia** which can be fatal. **NEET-PG High-Yield Pearls:** 1. **Chloramphenicol** is the most notorious drug associated with idiosyncratic aplastic anemia. 2. **Gold salts, Phenylbutazone, and Carbamazepine** are other frequent culprits of drug-induced aplastic anemia. 3. **TPMT testing** is recommended before starting Azathioprine to prevent life-threatening myelosuppression. 4. **Gray Baby Syndrome** is another specific toxicity of Chloramphenicol due to deficient glucuronidation in neonates.

Q: Pharmacovigilance is done for monitoring what?

Drug safety. **Explanation:** **Pharmacovigilance (PV)** is defined by the WHO as the science and activities relating to the detection, assessment, understanding, and prevention of adverse effects or any other drug-related problems. **Why Option C is Correct:** The primary objective of pharmacovigilance is to ensure **drug safety**. While Phase I-III clinical trials identify common side effects, they involve a limited number of participants. Once a drug is marketed (Phase IV), pharmacovigilance monitors its effects in the general population to identify rare, delayed, or unexpected adverse drug reactions (ADRs), ensuring the long-term safety profile of the medication. **Why Other Options are Incorrect:** * **Option A & B:** Drug pricing and unethical practices (like illegal marketing or clinical trial fraud) are overseen by regulatory and legal bodies (e.g., NPPA for pricing in India, or CDSCO/Ethics Committees for conduct), not by pharmacovigilance systems. * **Option D:** Monitoring students is an academic/administrative function and has no relation to clinical pharmacology. **High-Yield Clinical Pearls for NEET-PG:** * **Pharmacovigilance Programme of India (PvPI):** Launched in 2010; the National Coordinating Centre is the **Indian Pharmacopoeia Commission (IPC)**, Ghaziabad. * ** Uppsala Monitoring Centre (UMC), Sweden:** The international hub for global ADR monitoring. * **Spontaneous Reporting:** The most common method used in pharmacovigilance for reporting ADRs by healthcare professionals. * **Yellow Form:** The standard tool used for reporting suspected ADRs. * **Signal Detection:** The process of identifying a potential causal association between a drug and an adverse event that was previously unknown.

Q: Which of the following statements regarding aspirin toxicity is true?

Tinnitus is an early symptom.. **Explanation:** **1. Why Option A is Correct:** Tinnitus (ringing in the ears) is a classic, early, and sensitive indicator of salicylate toxicity (salicylism). It occurs due to the inhibition of cyclooxygenase (COX) and the subsequent alteration of ion transport in the stria vascularis of the cochlea, alongside increased pressure in the labyrinth. In clinical practice, the onset of tinnitus often serves as a warning sign to reduce the dose of aspirin. **2. Analysis of Incorrect Options:** * **Option B:** While 10–30 g is a significant amount, it is actually the **lethal dose** for adults, not just the threshold for poisoning. Mild toxicity (salicylism) can occur at much lower therapeutic doses if taken chronically. * **Option C:** While hyperthermia and tachypnea do occur, they are typically seen in **moderate to severe toxicity**. Tachypnea results from direct stimulation of the respiratory center, and hyperthermia results from the uncoupling of oxidative phosphorylation. Tinnitus precedes these systemic metabolic derangements. * **Option D:** Aspirin causes a **qualitative platelet defect** (by irreversibly inhibiting COX-1 and thromboxane A2 synthesis), leading to an increased bleeding time. It does not typically cause a decrease in platelet count (thrombocytopenia). **High-Yield Clinical Pearls for NEET-PG:** * **Acid-Base Balance:** Aspirin toxicity causes a unique **mixed acid-base disturbance**: Respiratory Alkalosis (early, due to hyperventilation) + Metabolic Acidosis (later, due to accumulation of organic acids). * **Management:** Treatment involves **Urinary Alkalinization** (using IV Sodium Bicarbonate) to enhance the excretion of salicylates (ion trapping). * **Done Nomogram:** Used to estimate the severity of toxicity based on serum salicylate levels (though clinical correlation is preferred).

Q: Which of the following drugs does NOT cause cholestasis with inflammation of bile ducts?

Astemizole. **Explanation:** Drug-induced liver injury (DILI) can manifest as hepatocellular necrosis, steatosis, or cholestasis. **Cholestatic jaundice** is characterized by the impairment of bile flow, which can occur with or without inflammation of the bile ducts (vanishing bile duct syndrome). **Why Astemizole is the correct answer:** Astemizole is a second-generation H1-antihistamine. While it was notorious for causing **QT interval prolongation** and *Torsades de Pointes* (leading to its withdrawal from many markets), it is not associated with cholestatic liver injury or bile duct inflammation. **Analysis of Incorrect Options:** * **Erythromycin:** Specifically the **estolate salt**, is a classic cause of cholestatic hepatitis. It typically presents with right upper quadrant pain and jaundice, mimicking acute cholecystitis. * **Amoxicillin-Clavulanic Acid:** This is one of the most common causes of drug-induced cholestatic liver injury worldwide. The injury is primarily attributed to the **clavulanic acid** component and often presents several weeks after stopping the therapy. * **Trimethoprim-Sulphamethoxazole (TMP-SMX):** Sulfonamides are well-known triggers for idiosyncratic liver injury, frequently presenting as mixed hepatocellular-cholestatic patterns with ductal involvement. **High-Yield Clinical Pearls for NEET-PG:** * **Pure Cholestasis (without inflammation):** Classically caused by **Anabolic steroids** and **Oral Contraceptive Pills (OCPs)**. * **Cholestatic Hepatitis (with inflammation):** Associated with **Erythromycin, Chlorpromazine,** and **Amoxicillin-Clavulanic acid**. * **Astemizole & Terfenadine:** High-yield for their **cardiotoxicity** (prolonged QT) when co-administered with CYP3A4 inhibitors like Ketoconazole or Macrolides.

Q: Which one of the following is ineffective in acute iron toxicity?

BAL. **Explanation:** Acute iron toxicity is a medical emergency characterized by gastrointestinal hemorrhage, metabolic acidosis, and multi-organ failure. The management focuses on preventing absorption and enhancing elimination through specific chelation. **Why BAL is the correct answer:** **BAL (British Anti-Lewisite/Dimercaprol)** is ineffective and contraindicated in iron toxicity. Dimercaprol forms a complex with iron that is **nephrotoxic**. It is primarily used for heavy metals like arsenic, mercury, and lead. Using it for iron poisoning can exacerbate renal damage rather than resolve the toxicity. **Analysis of Incorrect Options:** * **Desferrioxamine:** This is the **specific antidote of choice** for acute iron toxicity. It is administered parenterally and binds free iron to form ferrioxamine, which is excreted in the urine (often turning it a "vin-rose" color). * **Whole Bowel Irrigation (WBI):** Since iron tablets are radiopaque and do not bind to activated charcoal, WBI using Polyethylene Glycol (PEG) is the preferred method to mechanically flush unabsorbed tablets from the GI tract. * **Deferasirox:** This is an **oral iron chelator**. While primarily used for chronic iron overload (e.g., Thalassemia), it is pharmacologically active against iron, unlike BAL. However, Desferrioxamine remains the gold standard for *acute* cases. **High-Yield Clinical Pearls for NEET-PG:** 1. **Activated Charcoal:** Does **not** bind iron; it is useless in pure iron poisoning. 2. **Vin-Rose Urine:** A classic sign during Desferrioxamine therapy indicating the excretion of the iron-chelate complex. 3. **Abdominal X-ray:** Useful in diagnosis because iron tablets are radiopaque. 4. **Toxicity Stages:** Remember the "latent period" (Stage 2) where the patient appears to improve before crashing into hepatic failure and shock.

Question 1

All of the following are well-known ototoxic drugs except?

Accepted Answer

Acetaminophen

Answer

Aspirin

Answer

Aminoglycosides

Answer

Loop diuretics

Question 2

Red urine without RBCs is seen in which of the following conditions?

Accepted Answer

Following Rifampicin ingestion

Answer

Lupus nephritis

Answer

Pyelonephritis

Answer

Hemolytic uremic syndrome

Question 3

Which drug may lead to hemolysis in a child with G6PD deficiency?

Accepted Answer

Primaquine

Answer

Penicillin

Answer

Ceftriaxone

Answer

Erythromycin

Question 4

Which instructions should be included in the teaching care plan for a patient with cystitis receiving phenazopyridine?

Accepted Answer

Instruct the patient to stop taking phenazopyridine after painful urination is relieved.

Answer

Inform the patient that the urine will turn orange-red.

Answer

Instruct the patient to take phenazopyridine just before urination to relieve pain.

Answer

Advise the patient to discontinue prescribed antibiotics once painful urination is relieved.

Question 5

Which one of the following drugs is associated with the development of a lupus-like syndrome, especially in patients identified as "slow acetylators"?

Accepted Answer

Procainamide

Answer

Amiodarone

Answer

Clonidine

Answer

Nitroglycerin

Question 6

Bone marrow aplasia is not seen with which of the following drugs?

Accepted Answer

Levodopa

Answer

Azathioprine

Answer

Furosemide

Answer

Chloramphenicol

Question 7

Pharmacovigilance is done for monitoring what?

Accepted Answer

Drug safety

Answer

Drug price

Answer

Unethical practices

Answer

Pharmacology students

Question 8

Which of the following statements regarding aspirin toxicity is true?

Accepted Answer

Tinnitus is an early symptom.

Answer

A dose of 10-30 g can cause poisoning.

Answer

Hyperthermia and tachypnea are early complications.

Answer

Aspirin causes thrombocytopenic purpura.

Question 9

Which of the following drugs does NOT cause cholestasis with inflammation of bile ducts?

Accepted Answer

Astemizole

Answer

Erythromycin

Answer

Amoxicillin clavulanic acid

Answer

Trimethoprim sulphamethoxazole

Question 10

Which one of the following is ineffective in acute iron toxicity?

Accepted Answer

BAL

Answer

Desferrioxamine

Answer

Whole bowel irrigation

Answer

Deferasirox

Clinical Pharmacology and Drug Toxicity — MCQs

Clinical Pharmacology and Drug Toxicity — MCQs

On this page

Practice by Chapter

Want unlimited practice?